Innovative Trial for Understanding the Impact of Targeted Therapies in NF2 (INTUITT-NF2)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Neurofibromatosis 2 (nf2)
  • Age: Between 12 Year(s) - 100 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1) Must have a pathogenic variantin the NF2 gene (either in the germline or in two NF2-related tumors) OR a confirmed diagnosis of NF2. 2) Life expectancy of greater than 1 year. 3) Must have a target NF2-related tumor with the following qualities:

You may not be eligible for this study if the following are true:

  • 1) Participants who have had chemotherapy within a minimum of 4 weeks prior to Master Study registration (or a minimum of 5 half-lives and resolution to baseline of toxicities unless there are irreversible toxicities from prior drug that do not influence

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.